Home Spirometry as a Clinical Trial Endpoint in People with Cystic Fibrosis: Results of the OUTREACH Study
{{output}}
Rationale: Change from baseline in FEV1 is a primary endpoint for many traditional clinical trials in cystic fibrosis (CF). Home spirometry holds promise as an endpoint for decentralized clinical trials, yet its cross sectional a... ...
